Immunovia: € 4.25M

GAEU Consulting helped us to structure our projects based on the criterias applied in the SME instrument. During a full-day workshop we discussed the application strategy and how the clinical content was to be presented. Then GAEU wrote the application and guided us through the process. The Horizon 2020 experts in GAEU proved to be very efficient and professional in their work and had great commitment and interest in our project which resulted in a grant of € 4,250,000 for clinical validation of a biomarker for early diagnosis of pancreatic cancer. We are very pleased with GAEU Consulting’s performance and we highly recommend the company for similar efforts. GAEU Consulting is an excellent advisor suited for excellent innovation projects in the Horizon 2020!

Mats Grahn, vd, Immunovia AB